Group One Trading
FPRX

Group One Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Group One Trading’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,786
Closed -$119K – 8256
2020
Q4 		$81K Buy
4,786
+1,786
+60% +$22.4K ﹤0.01% 4713
2020
Q3 		$14K Buy
+3,000
New +$15.2K ﹤0.01% 5304
2019
Q2 		– Sell
-1,476
Closed -$14.1K – 5621
2019
Q1 		$20K Hold
1,476
– – ﹤0.01% 4041
2018
Q4 		$14K Sell
1,476
-8,375
-85% -$99.7K ﹤0.01% 4171
2018
Q3 		$137K Sell
9,851
-13,100
-57% -$195K ﹤0.01% 3298
2018
Q2 		$363K Buy
+22,951
New +$401K ﹤0.01% 2572
2018
Q1 		– Sell
-1,206
Closed -$26K – 5520
2017
Q4 		$26K Buy
+1,206
New +$38.8K ﹤0.01% 4064
2016
Q3 		– Sell
-351
Closed -$15K – 5068
2016
Q2 		$15K Sell
351
-1,500
-81% -$65.2K ﹤0.01% 3926
2016
Q1 		$75K Hold
1,851
– – ﹤0.01% 3014
2015
Q4 		$77K Buy
+1,851
New +$62K ﹤0.01% 3161

Group One Trading's FPRX Position: Q1 2021 in Review

Group One Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 4,786 shares — an estimated $119K sold.

Group One Trading first reported a position in FPRX in Q4 2015 and held it in 10 quarters. The position peaked at $363K in Q2 2018. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • Group One Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Group One Trading sold 4,786 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $119K.
  • Group One Trading first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 10 quarters.
  • Group One Trading's Five Prime Therapeutics, Inc. position peaked at $363K in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.